Top Markets
#1 Black Phoenix Black Phoenix +166.18%
#2 Islamic Coin Islamic Coin +158.21%
#3 Glidr Glidr +58.56%
#4 Cryptopia Cryptopia +20.80%
#5 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.53%
#6 MarsCoin MarsCoin +13.34%
#7 Test Test +12.58%
#8 Wrapped Bitcoin (PulseChain) Wrapped Bitcoin (PulseChain) +11.52%
#9 Palladium Network Palladium Network +9.76%
#10 Useless Coin Useless Coin +9.21%
Coin of the day
Black Phoenix Black Phoenix
Setări
Limbă
ROMâNă
Monedă
USD
Temă
VIA Pharmaceuticals, Inc. VIA Pharmaceuticals, Inc.

VIA Pharmaceuticals, Inc.

VIAP
Rang în acțiuni #41780
VIA Pharmaceuticals, Inc. is an emerging biotechnology company primarily... VIA Pharmaceuticals, Inc. is an emerging biotechnology company primarily focused on discovering and advancing therapeutic compounds for cardiovascular and metabolic disorders. The firm is building a portfolio of small-molecule drug candidates designed to tackle the root causes of these health issues, such as vascular inflammation, elevated cholesterol and triglyceride levels, and insulin resistance or diabetes. Notable candidates in their development pipeline include: VIA-3196: A liver-specific thyroid hormone receptor (THR) beta agonist, poised for Phase 1 clinical studies. This drug aims to mitigate dyslipidemia, addressing high LDL cholesterol, elevated triglycerides, and Lp(a) levels. A Diacylglycerol Acyl Transferase 1 (DGAT1) inhibitor: Currently in preclinical development for treating type 2 diabetes, with promising potential for weight management and other lipid disorders. VIA-2291: A 5-Lipoxygenase inhibitor that has successfully completed its third Phase 2 clinical trial. Its purpose is to target atherosclerotic plaque, a significant contributor to heart attacks, strokes, and various other vascular diseases. VIA Pharmaceuticals has also forged two research, development, and commercialization agreements with Hoffman-LaRoche Inc. and Hoffman-LaRoche Ltd. These collaborations pertain to their THR beta agonist program and several compounds from their preclinical DGAT1 metabolic disorders initiative. Established in 2004, the company's headquarters are located in San Francisco, California.
Preț acțiune
$0.0005
Ultima sincronizare: 2026-08-11
Capitalizare de piață
$10.28K
Schimbare (1 zi)
0.00%
Schimbare (1 an)
0.00%
Țară
US
Tranzacționează VIA Pharmaceuticals, Inc. (VIAP)

Categorie

Healthcare
Marja operațională pentru VIA Pharmaceuticals, Inc. (VIAP)
Marja operațională la 2026 TTM: 0.00%
Conform celor mai recente rapoarte financiare și prețului acțiunilor VIA Pharmaceuticals, Inc., marja operațională curentă (TTM) este 0.00%. La finalul anului 2026, compania avea o marjă operațională de 0.00%.
Istoricul marjei operaționale pentru VIA Pharmaceuticals, Inc. din 2026 până în 2026
Marja operațională la sfârșitul fiecărui an
An Marja Operațională Schimbă
Nu sunt suficiente date pentru perioada selectată.
Marja operațională pentru companii similare sau concurente
Companie Marja Operațională Diferență în marja operațională Țara
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
67.93% -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
0.00% -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
0.00% -
FR
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
0.00% -
IT
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
0.77% -
US
Ce este marja operațională a unei companii?
Marja operațională este un indicator esențial pentru evaluarea profitabilității unei companii. Marjele operaționale mai mari sunt de obicei mai bune, deoarece arată că o companie poate vinde produsele sau serviciile sale la prețuri mult mai mari decât costurile de producție. Marja operațională se calculează împărțind profitul companiei la venitul său.